Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Stuve

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Neurologia I Neurochirurgia Polska|June 17, 2022
Clinical trials in multiple sclerosis: past, present, and futureNavid Manouchehri, Afsaneh Shirani, Victor H Salinas, et al.
Journal of Central Nervous System Disease|November 25, 2021
Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case reportAfsaneh Shirani, Scott R Dalton, Eric J Avery, et al.
Therapeutic Advances in Neurological Disorders|June 28, 2019
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markersOlaf Stuve, Per Soelberg Soerensen, Thomas Leist, et al.
Therapeutic Advances in Neurological Disorders|October 7, 2024
Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsyAfsaneh Shirani, Nil Saez-Calveras, Jack P Antel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
The Lancet. Neurology|September 22, 2006
Optical coherence tomography in multiple sclerosisElliot Frohman, Fiona Costello, Robert Zivadinov, et al.
Plos One|August 9, 2018
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitisMatthew Cummings, Anitha Christy Sigamani Arumanayagam, Picheng Zhao, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Stephen Reingold, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2015
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overviewRuth Ann Marrie, Jeffrey Cohen, Olaf Stuve, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Neurologia I Neurochirurgia Polska|June 17, 2022
Clinical trials in multiple sclerosis: past, present, and futureNavid Manouchehri, Afsaneh Shirani, Victor H Salinas, et al.
Journal of Central Nervous System Disease|November 25, 2021
Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case reportAfsaneh Shirani, Scott R Dalton, Eric J Avery, et al.
Therapeutic Advances in Neurological Disorders|June 28, 2019
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markersOlaf Stuve, Per Soelberg Soerensen, Thomas Leist, et al.
Therapeutic Advances in Neurological Disorders|October 7, 2024
Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsyAfsaneh Shirani, Nil Saez-Calveras, Jack P Antel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
The Lancet. Neurology|September 22, 2006
Optical coherence tomography in multiple sclerosisElliot Frohman, Fiona Costello, Robert Zivadinov, et al.
Plos One|August 9, 2018
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitisMatthew Cummings, Anitha Christy Sigamani Arumanayagam, Picheng Zhao, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2015
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Stephen Reingold, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 28, 2015
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overviewRuth Ann Marrie, Jeffrey Cohen, Olaf Stuve, et al.
Pageof 9